Bryan D. Cox
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Computational Drug Discovery Methods
Papers in
-
- Hepatitis B Virus Studies 6
-
- HIV/AIDS drug development and treatment 3
- Co-authors
- Raymond F. Schinazi (15 shared papers)Franck Amblard (13 shared papers)Leda Bassit (11 shared papers)Richard A. Stanton (1 shared paper)Dennis C. Liotta (6 shared papers)James P. Snyder (5 shared papers)Donald D. Muccio (4 shared papers)Lawrence J. Wilson (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Antiviral Research (2 papers)ACS Medicinal Chemistry Letters (2 papers)Journal of Hepatology (2 papers)PLoS Pathogens (2 papers)
- Partner nations
- United StatesFranceBrazil
In The Last Decade
Bryan D. Cox
32 papers receiving 882 citations
Bryan D. Cox's Hit Papers
Peers
Comparison fields: 5 of 75
- Virology 73
- Computational Theory and Mathematics 122
- Public Health, Environmental and Occupational Health 195
- Epidemiology 151
- Molecular Medicine 25
Countries citing papers authored by Bryan D. Cox
This map shows the geographic impact of Bryan D. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan D. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan D. Cox more than expected).
Fields of papers citing papers by Bryan D. Cox
This network shows the impact of papers produced by Bryan D. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan D. Cox. The network helps show where Bryan D. Cox may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan D. Cox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 103 | |
| 2 | AI is a viable alternative to high throughput screening: a 318-target study Hit paper breakdown → | 2024 | 92 |
| 3 | 2020 | 74 | |
| 4 | 2015 | 58 | |
| 5 | 2013 | 47 | |
| 6 | 2014 | 47 | |
| 7 | 2017 | 41 | |
| 8 | 2015 | 40 | |
| 9 | 2019 | 38 | |
| 10 | 2019 | 38 | |
| 11 | 2019 | 34 | |
| 12 | 2020 | 31 | |
| 13 | 2014 | 25 | |
| 14 | 2010 | 22 | |
| 15 | 2017 | 22 | |
| 16 | 2022 | 21 | |
| 17 | 2005 | 20 | |
| 18 | 2018 | 17 | |
| 19 | 2017 | 15 | |
| 20 | 2017 | 14 |
About Bryan D. Cox
Bryan D. Cox is a scholar working on Epidemiology, Infectious Diseases, Virology, Public Health, Environmental and Occupational Health and Computational Theory and Mathematics, having authored 33 papers that have together received 907 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), Mosquito-borne diseases and control (5 papers), Receptor Mechanisms and Signaling (4 papers), HIV/AIDS drug development and treatment (3 papers), Chemokine receptors and signaling (3 papers), Computational Drug Discovery Methods (3 papers), HIV Research and Treatment (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Virology (73 citations), Computational Theory and Mathematics (122 citations), Public Health, Environmental and Occupational Health (195 citations), Epidemiology (151 citations) and Molecular Medicine (25 citations). Bryan D. Cox has collaborated with scholars based in United States, France and Brazil. Frequent co-authors include Raymond F. Schinazi, Franck Amblard, Leda Bassit, Richard A. Stanton, Dennis C. Liotta, James P. Snyder, Donald D. Muccio, Lawrence J. Wilson, Tugba Tastemel Ozturk and Olivia Ollinger Russell. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Antiviral Research, ACS Medicinal Chemistry Letters, Journal of Hepatology and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.